透過您的圖書館登入
IP:18.227.161.207
  • 期刊

慢性特發性便秘之藥物治療(上)-美國腸胃醫學會2023年臨床治療指引

摘要


慢性特發性便秘在臨床上尤其門診是很常遇到的主訴,在正確診斷後要如何選擇正確的藥物,並且給予正確的劑量與評估常見副作用與成效是臨床醫師應該要熟稔的。本文以2023年美國腸胃醫學會公布之最新治療指引為本,整理出臨床重點與重要藥物之常見劑量,證據,常見副作用。此篇為上篇,收入纖維、滲透性瀉藥與部分刺激性瀉藥之篇幅。下篇會收入部分刺激性瀉藥、分泌性瀉藥與5-HT4 agonist。希望能提供給臨床醫師與慢性特發性便秘病患更好的治療與照護。

參考文獻


Palsson OS, Whitehead W, Törnblom H, et al. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology 2020;158:1262-73.e1263.
Vriesman MH, Koppen IJN, Camilleri M, et al. Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol 2020;17:21-39.
Luthra P, Camilleri M, Burr NE, et al. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2019;4:831-44.
Rao SSC, Brenner DM: Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. Am J Gastroenterol 2021;116:1156-81.
Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995;40:349-56.

延伸閱讀